Proteasome inhibition for the treatment of glioblastoma-Reference-Cited by-同舟云学术

Proteasome inhibition for the treatment of glioblastoma

Published:2020-08-10 Issue:10 Volume:29 Page:1133-1141
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Roth Patrick¹,Mason Warren P.²,Richardson Paul G.³,Weller Michael¹

Affiliation:

1. Department of Neurology, Brain Tumor Center and Comprehensive Cancer Center Zurich, University Hospital and University of Zurich, Zurich, Switzerland

2. Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

3. Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1803827

Reference88 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

3. An Integrated Genomic Analysis of Human Glioblastoma Multiforme

4. Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009

5. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells;Pharmaceuticals;2024-08-20

2. Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial;Neuro-Oncology;2024-03-19

3. Assessment of the effects of amphiphilic poly (N‑vinylpyrrolidone) nanoparticles loaded with bortezomib on glioblastoma cell lines and zebrafish embryos;Biomedical Reports;2024-01-17

4. Updates of primary central nervous system lymphoma;Therapeutic Advances in Hematology;2024-01

5. Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics;Cancer Cell International;2023-10-11